NEU 2.31% $19.02 neuren pharmaceuticals limited

Ann: Comment on research report, page-243

  1. 1,370 Posts.
    lightbulb Created with Sketch. 292
    I dont recall the $100/sh unrisked being mentioned, to be honest, except for a few posters here performing their own calculations.

    Given the report is forecasting over the next 12 months (and more more), I feel $60 is a reasonable estimate.

    Now - if we fast forward to June and PhII is successful, and they perform another unrisked 12 month forecast, I would expect this $60 to be much higher.

    I think we need to differentiate between a SP valuation (risked vs value) for a 12 month period as opposed to longer, or definitive "end game" values.

    As usual all IMO.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.02
Change
-0.450(2.31%)
Mkt cap ! $2.428B
Open High Low Value Volume
$19.49 $19.56 $18.60 $11.78M 623.8K

Buyers (Bids)

No. Vol. Price($)
1 1714 $18.98
 

Sellers (Offers)

Price($) Vol. No.
$19.03 2545 2
View Market Depth
Last trade - 16.10pm 11/06/2024 (20 minute delay) ?
Last
$18.88
  Change
-0.450 ( 3.07 %)
Open High Low Volume
$19.44 $19.55 $18.60 149013
Last updated 15.59pm 11/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.